Followers
0
Following
0
Blog Posts
0
Threads
431
Blogs
Threads
Portfolio
Follower
Following
2020-04-21 16:20 | Report Abuse
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET
NEXGRAM HOLDINGS BERHAD
Type Announcement
Subject TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET
The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 16 April 2020 entered into a Strategic Sourcing Agreement (“Agreement”) with PT Mitra Abadi Propertindo Utama (“MAPU”) to sell to MAPU for the latter to promote, market and distribute Detection and Diagnostic Kit and Rapid Test Kit, and other medical supplies products in Indonesia and certain part of South East Asia market, as per the terms and condition of the Agreement.
Please refer to the attachment for details of the announcement.
2020-04-21 13:16 | Report Abuse
@lancefire ;) tak mau layan them ... make sure our counter Heng Ong huat :)
2020-04-21 13:08 | Report Abuse
halo xcalibra see our commentlah same person... our comment all tak sama counter... stupid to the max ... ops sorry I beg tahan Liao...u and your twins invest AA terus come to scomnet counter to attack ... kids also know lo... tiruan capAA
2020-04-21 12:14 | Report Abuse
Where is the hardcore promoters like @gemsh...? So quiet now...
Bro apa stock you buy give some recommend leh ,why u rindu saya izit ;)
2020-04-21 12:06 | Report Abuse
Posted by Xcalibre > Apr 21, 2020 11:11 AM | Report Abuse
More of @gemshi* rather than @gemstar....
Xcalibre
2 posts
Posted by Xcalibre > Apr 21, 2020 11:19 AM | Report Abuse
@gemshi* must be burying his head in the sand like ostrich
Why mau to bury head to sand... all drop ma.. only scomnet counter drop saja meh ...
@x calibra green u tak datang kecam...
2020-04-21 12:01 | Report Abuse
Hai Nike shoe seller today so free ah... market drop u baru come to kecam eh... ppl win money Liao u baru Datang
2020-04-21 12:00 | Report Abuse
Hai bro still alive lol ;)
2020-04-17 18:33 | Report Abuse
good news to scomnet kaki..
2020-04-17 18:31 | Report Abuse
@yeoqian
My friend share to me... and told me to hold ;)
2020-04-17 11:51 | Report Abuse
Sharing not hardcore promoter;)
KLSE:SCOMNET Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 11.0%
Perpetual Growth Rate 10-Year MY Government Bond Rate 3.4%
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
Calculation of Discount Rate/ Cost of Equity for KLSE:SCOMNET
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year MY Govt Bond Rate 3.4%
Equity Risk Premium S&P Global 7.0%
Electrical Unlevered Beta Simply Wall St/ S&P Global 1.13
Re-levered Beta = 0.33 + [(0.66 * Unlevered beta) * (1 + (1 - tax rate) (Debt/Market Equity))]
= 0.33 + [(0.66 * 1.127) * (1 + (1 - 24.0%) (0%))] 1.085
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm) 1.085
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 3.42% + (1.085 * 6.96%) 10.97%
Discounted Cash Flow Calculation for KLSE:SCOMNET using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Supercomnet Technologies Berhad is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
KLSE:SCOMNET DCF 1st Stage: Next 5 year cash flow forecast
Levered FCF (MYR, Millions) Source Present Value
Discounted (@ 10.97%)
2020 32.13 Est @ 49.4% 28.96
2021 43.58 Est @ 35.61% 35.38
2022 54.88 Est @ 25.95% 40.16
2023 65.42 Est @ 19.19% 43.13
2024 74.88 Est @ 14.46% 44.49
2025 83.22 Est @ 11.15% 44.56
2026 90.57 Est @ 8.83% 43.7
2027 97.1 Est @ 7.21% 42.21
2028 102.99 Est @ 6.07% 40.35
2029 108.43 Est @ 5.28% 38.28
Present value of next 5 years cash flows MYR401
KLSE:SCOMNET DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value FCF2029 × (1 + g) ÷ (Discount Rate – g)
= MYR108.427 x (1 + 3.42%) ÷ (10.97% - 3.42% ) MYR1,484.57
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
MYR1,485 ÷ (1 + 10.97%)10 MYR524.1
KLSE:SCOMNET Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= MYR401 + MYR524 MYR925.1
Equity Value per Share
(MYR) = Total value / Shares Outstanding
= MYR925 / 643 MYR1.44
KLSE:SCOMNET Discount to Share Price
Calculation Result
Value per share (MYR) From above. MYR1.44
Current discount Discount to share price of MYR0.78
= -1 x (MYR0.78 - MYR1.44) / MYR1.44 46.1%
2020-04-17 10:58 | Report Abuse
Below are the data sources, inputs and calculation used to determine the intrinsic value for Hong Leong Industries Berhad.
KLSE:HLIND Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.8%
Perpetual Growth Rate 10-Year MY Government Bond Rate 3.4%
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
Calculation of Discount Rate/ Cost of Equity for KLSE:HLIND
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year MY Govt Bond Rate 3.4%
Equity Risk Premium S&P Global 7.0%
Industrials Unlevered Beta Simply Wall St/ S&P Global 0.87
Re-levered Beta = 0.33 + [(0.66 * Unlevered beta) * (1 + (1 - tax rate) (Debt/Market Equity))]
= 0.33 + [(0.66 * 0.868) * (1 + (1 - 24.0%) (1.96%))] 0.920
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm) 0.920
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 3.42% + (0.920 * 6.96%) 9.83%
Discounted Cash Flow Calculation for KLSE:HLIND using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Hong Leong Industries Berhad is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
KLSE:HLIND DCF 1st Stage: Next 5 year cash flow forecast
Levered FCF (MYR, Millions) Source Present Value
Discounted (@ 9.83%)
2020 515.72 Est @ 2.93% 469.58
2021 531.59 Est @ 3.08% 440.73
2022 548.5 Est @ 3.18% 414.07
2023 566.34 Est @ 3.25% 389.28
2024 585.04 Est @ 3.3% 366.16
2025 604.57 Est @ 3.34% 344.54
2026 624.9 Est @ 3.36% 324.26
2027 646.02 Est @ 3.38% 305.23
2028 667.93 Est @ 3.39% 287.35
2029 690.65 Est @ 3.4% 270.54
Present value of next 5 years cash flows MYR3,611
KLSE:HLIND DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value FCF2029 × (1 + g) ÷ (Discount Rate – g)
= MYR690.645 x (1 + 3.42%) ÷ (9.83% - 3.42% ) MYR11,151.18
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
MYR11,151 ÷ (1 + 9.83%)10 MYR4,368.15
KLSE:HLIND Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= MYR3,611 + MYR4,368 MYR7,979.15
Equity Value per Share
(MYR) = Total value / Shares Outstanding
= MYR7,979 / 314 MYR25.41
KLSE:HLIND Discount to Share Price
Calculation Result
Value per share (MYR) From above.
2020-04-17 10:12 | Report Abuse
Yah cash flow and good dividend better than asb
2020-04-16 19:13 | Report Abuse
Pos shareholders
Etika Strategi Sdn. Bhd.
53.5%
Kumpulan Wang Persaraan
7.93%
Employees Provident Fund of Malaysia
5.16%
Principal Asset Management Berhad
3.87%
The Vanguard Group, Inc.
1.47%
Permodalan Nasional Berhad
1.36%
Urusharta Jamaah Sdn Bhd
0.92%
Union Bancaire Privee Asset Management LLC
0.77%
Bank Negara Malaysia National Trust Fund
0.38%
ValueCap Sdn Bhd
0.37%
Dimensional Fund Advisors L.P.
0.34%
2020-04-16 16:43 | Report Abuse
So who the hardcore promoter that push this stock up today... :)
2020-04-15 20:00 | Report Abuse
@t Nike now is year 2020 come on lah ppl look forward not backward!SCOMNET's earnings have grown significantly by 53.8% per year over the past 5 years.
2020-04-15 17:30 | Report Abuse
@t nike then who ask u to read and reply my posting, Those ppl also post FACTS about this scomnet company that their earning and invest in medical supply ma... to u.s and Europe ..
2020-04-15 17:06 | Report Abuse
Yah memang free place to comment but why wanna come here to say hardcore promoter lah, ppl money ppl choice wanna buy or sell...
2020-04-15 12:11 | Report Abuse
@t_nike so what your problem , ppl wanna promote this counter... and u keep attack ... tak beli sudahlah keep come scomnet here to kacau... why u wanna buy cheap cheap izit
2020-04-15 10:42 | Report Abuse
Time to wake up this dragon
2020-04-15 09:50 | Report Abuse
Safe price to enter 0.010 to 0.015
2020-04-15 09:31 | Report Abuse
Those untung at lambo can jump ship to join next...
2020-04-15 09:29 | Report Abuse
Around the world short medical supply ... hopefully their results can kaboom
2020-04-15 09:14 | Report Abuse
See can surpass lambo 0.025
2020-04-15 08:41 | Report Abuse
Next easily up than lambo...
2020-04-14 23:08 | Report Abuse
Lambo sold 0.020 100% gain tqvm, next my pisang goreng counter to play..
2020-04-14 23:02 | Report Abuse
Tomorrow next Will join lambo...
Stock: [NEXGRAM]: NEXGRAM HOLDINGS BERHAD
2020-04-21 16:28 | Report Abuse
Nexgram has teamed up with Indonesia’s PT Mitra Abadi Propertindo Utama (MAPU) to sell medical test kits in Indonesia and other Southeast Asian markets.
MAPU has estimated that it will require 500,000 sets of detection and diagnostic kits and 500,000 sets of rapid test kits this year.